Timpad, Marshida M.
HRN: 24-70-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
AMPICILLIN 1GM (VIAL)
03/22/2024
03/29/2024
IV
2g
Now Then Q6 ANST
PROM X 1 Hr; Ruptured BOW
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes